SIGLEC10巨细胞通过抑制CD8T细胞功能来驱动胃癌的进展

Yixian Guo1, Shouyu Ke2, Feng Xie3,4

  • 1GI Division, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200025, China.

概括

在巨细胞上SIGLEC10抑制了胃癌中T细胞的功能. 阻止SIGLEC10可能会增强免疫疗法,并预测患者的预后.